SS Innovations International Inc. (NASDAQ: SSII), a developer of surgical robotic technologies, has expanded its international footprint with the launch of Sri Lanka's first robotic cardiac surgery program at Kings Hospital Colombo. The program is powered by the company's SSi Mantra 3.0 surgical robotic system, according to a recent announcement from NetworkNewsWire.
The program began with a robotic-assisted left internal mammary artery takedown performed by company founder and Chairman Dr. Sudhir Srivastava alongside Kings Hospital cardiothoracic surgeon Dr. Rajitha DeSilva. The hospital reportedly completed more than 25 robotic procedures within the first three weeks, demonstrating rapid adoption of the technology.
This launch adds to SS Innovations' international expansion. At the end of the second quarter of 2026, the company reported 224 cumulative SSi Mantra installations across 12 countries. Quarterly revenue increased 39% year over year to $13.9 million, while robotic procedures rose 143% to 2,528. These figures highlight increased utilization of its installed systems and potential opportunities for recurring revenue from surgical instruments and consumables.
The news matters for investors and the medical technology industry because it signals growing global acceptance of robotic-assisted surgery, particularly in cardiac care. The procedure volume growth outpaces installation growth, indicating that hospitals are increasingly using the systems, which could drive recurring revenue streams. SS Innovations is also pursuing broader market access, with U.S. FDA clearance targeted for the first quarter of 2027 and European CE marking targeted for the end of 2026. These regulatory milestones could significantly expand the company's addressable market.
For readers, this development may have implications for the accessibility of advanced surgical care. SS Innovations aims to make robotic surgery affordable and accessible to a larger segment of the global population. The company's product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. Headquartered in India, SS Innovations is a U.S. company focused on expanding the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. More information is available at SSInnovations.com.
As the company continues its international expansion, industry observers will be watching whether the momentum in procedure growth and installations can be sustained. The latest news and updates relating to SSII are available in the company's newsroom at https://nnw.fm/SSII. For a deeper look at the company's profile, visit SS Innovations International (NASDAQ: SSII).
NetworkNewsWire is a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries. For full terms of use and disclaimers, see https://www.NetworkNewsWire.com/Disclaimer.
